Navigation Links
Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari
Date:11/20/2008

NanoMedical Systems Inc., (NMS), an Austin-based startup cofounded by Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston (UTHSC-Houston), to improve the effectiveness of anti-cancer agents and other medications, has received a record $3.5 million Commercialization Award through the Texas Emerging Technology Fund (ETF).

NMS was one of six companies that received the ETF awards, which were announced by Texas Gov. Rick Perry on Tuesday, Nov. 18.

The grant will help accelerate the completion of engineering and pre-clinical testing for a device, which will allow for a controlled dose of medicine to be released into the bloodstream over many weeks or months. The device will be a safer, more reliable and less costly alternative to a long series of injections or clinical visits.

"From the information I have, this is the largest commercialization award (to private companies in collaboration with a university for product development) awarded from the emerging technology fund to date. They've gone to $3 million twice and $2 million five times out of 48 commercialization awards," said Wayne R. Roberts, associate vice president for public policy at the UT Health Science Center at Houston.

The goal of the ETF Commercialization Awards is to grow new small businesses and existing businesses to accelerate new products and services to the marketplace. The ETF also offers Research Superiority Acquisition Awards, which are designed to bring the best and brightest researchers in the world to Texas. Ferrari was a recipient of a $2.5 million Research Superiority Award in August of 2006.

"The NMS partnership with UTHSC-Houston is breaking down the barriers to successful commercialization of nano-bio technology by leading the way in the nanofabrication of components suitable for use in pre-clinical and clinical studies, a key goal of the Governor's office," said Peter Davies, M.D., Ph.D., executive vice president for research at the health science center.

The company's basic technology was developed by Ferrari, who is deputy chairman of the Department of Biomedical Engineering, a joint venture among UTHSC-Houston, The University of Texas at Austin and The University of Texas M. D. Anderson Cancer Center.

Each small silicon chip through which the NMS device will deliver medication into the bloodstream has 100,000 nanochannels, each precisely dimensioned from engineered materials to a size near that of a drug molecule. The company is focusing on an anti-cancer drug that is used in long-term therapy for its first commercially viable product. Its research and development activities over the next year will include further design and testing of the device's chip and capsule, animal studies, and applications with the federal Food and Drug Administration.

"This is a dream situation," Ferrari said. "We have an opportunity to take decisive strides against cancer, working all together as a team: the company, the State of Texas, our university laboratory and our collaborating partners at several Texas institutions. University laboratories alone cannot bring medical innovations into the clinic; they need companies that will turn basic discoveries into new medical treatments and clinical devices."

Ferrari continued, "That is why it is such a privilege to 'fly in formation' with NMS: We can make a real difference in patient care. I am confident that the work we are doing will have benefits beyond cancer, with applications to cardiovascular and infectious diseases, among others. We will continue to explore new approaches in civilian medicine, but also in space and military medicine, with the support of the sponsors of our university laboratory research: NASA, the U.S. Department of Defense and the National Institutes of Health."


'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3042
University of Texas Health Science Center at Houston
Source:Eurekalert

Related biology news :

1. Texas researchers and educators head for Antarctica
2. Ceres and Texas A&M to develop and market high-biomass sorghum for biofuels
3. Gulf of Mexico dead zone to be studied by University of Texas at Austin marine scientists
4. UT Southwestern scientist honored among best in Texas research
5. Rices West honored as one of Texas best researchers
6. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
7. Texas A&M testing oral contraceptives for animals
8. Texas A&M scientists say early Americans arrived earlier
9. Researchers confirm dead zone off Texas coast since 1985
10. Underwater microscope helps prevent shellfish poisoning along Gulf Coast of Texas
11. UTMB inventions win University of Texas System commercialization awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
Breaking Biology Technology: